SMEs

DREAMINSIGHT Co.,Ltd. Subsidiary Unicorn Trophy Entertainment Signs Up-and-Coming Singer-Songwriter Yoon Yoon

KIM JI-WAN
2026-10-19 09:41:59
[Edaily Reporter KIM JI-WAN ] DREAMINSIGHT Co.,Ltd.(362990) ’s subsidiary, Unicorn Trophy Entertainment, is expanding its music business by signing up-and-coming singer-songwriter Yoon Yoon.

Rising singer-songwriter Yoon Yoon. (Courtesy of DREAMINSIGHT Co.,Ltd.)


According to DREAMINSIGHT Co.,Ltd. on the 19th, Unicorn Trophy Entertainment recently signed an exclusive contract with Yoon Yoon. Yoon Yoon is a new artist known for her powerful vocals and unique band sound, and she began her music career last June with the release of her debut single, “The Memory Shop.”

Yoon Yoon is a singer-songwriter who not only plays the guitar and piano but also writes her own lyrics and composes her own music. She is currently pursuing a master’s degree in TONGYANG painting at Ewha Womans University Graduate School, where she continues to create works that blend music and art.

This contract was finalized following the discovery of an online performance video. After coming across a video of Yoon Yoon busking posted on YouTube, Unicorn Trophy Entertainment visited venues in the Hongdae area multiple times to assess her musical talent and stage presence. Subsequently, recognizing her high potential for growth, the agency moved forward with an exclusive contract.

New releases from the agency’s existing artists are also on the horizon. Guitarist and singer-songwriter Jang Ha-eun plans to release a new mini-album (EP) on December 10. Centered on the theme of “growth,” the album will feature six tracks, with Jang Ha-eun writing the lyrics and composing the music for all of them.

Singer Han Kyung-il is also preparing to release a new song later this month. Han Kyung-il, who debuted in the music industry in 2002, has built widespread recognition by releasing numerous hit songs such as “Half of My Life” and “Sad Invitation.” Recently, he has continued his activities by appearing on a TV CHOSUN music program, where he showcased his enduring vocal prowess.

Unicontrophy Entertainment is expanding its business base not only in the music industry but also in variety shows, broadcasting, and digital content. The agency currently represents comedians Kim Won-hyo and Shim Jin-hwa, as well as chef Jang Ho-jun, and is developing its content business through the operation of its own YouTube channel and the production of web variety shows.

Its parent company, DREAMINSIGHT Co.,Ltd., has a strategy of linking its entertainment business to strengthening its advertising and marketing competitiveness. It is expanding its business scope by combining its in-house production infrastructure and the content creation capabilities of its artists with its existing advertising agency business.

In particular, the company is focusing on securing its own intellectual property (IP) by leveraging its artists and creators. The plan is to move away from relying on external content and instead handle planning, production, and distribution in-house to uncover new revenue streams and improve business profitability.

Economy

Corporation

IT·Science

Economy

HYUNDAI WIA Spins Off Defense Business to Focus on 'Mobility and Robotics'… Special Business Unit Valued at 480 Billion Won (Comprehensive)

HYUNDAI WIA(011210)is transferring its Special Business Division—which handles the defense sector—to HYUNDAI ROTEM and accelerating its business restructuring centered on future mobility. The proceeds…
2026-10-19 11:54:32

Corporation

Bibigo Kim Bugaek Sells 500,000 Packages… CJ CheilJedang Corp Targets the K-Snack Market with ‘Canned Kim’

CJ CheilJedang Corp. is launching a new canned seaweed product, riding on the popularity of “Bibigo Kim Bugaek,” and accelerating its push into the global K-snack market. The company plans to lead the…
2026-10-19 10:21:41

IT·Science

MedPacto, Inc. Adds Medium-Dose Group to Phase 2 Trial of Baekto-Se-Tip for Osteosarcoma… Approved by the U.S. FDA

MedPacto, Inc. Research Institute. (Photo: MedPacto, Inc.) MedPacto, Inc.(235980)will add a medium-dose patient group to its ongoing Phase 2 clinical trial of “Vactosertib” for osteosarcoma patien…
2026-10-19 11:40:03